SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].

NIH RePORTER · NIH · N02 · $10,800 · view on reporter.nih.gov ↗

Abstract

This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to understand the basis of pain and enhance clinical pain management. Drug Metabolism Pharmacokinetics The Contractor shall provide consulting support services to the NIH Blueprint Neurotherapeutics Network as follows: • Evaluate pharmacokinetics study protocols and data to identify potential drug discovery and development challenges. Recommend strategies to address these challenges. • Develop plans to assist NIH BPN staff in strategically managing pharmacokinetic programs which facilitate assay development, exploratory chemistry, lead optimization, formulation activities, investigational new drug (IND) enabling, and clinical studies. • Assist NIH BPN staff to design investigative pharmacokinetics studies, including study strategy and experimental design. Provide advice regarding recommended study milestones and prepare milestone reports are needed. • Facilitate Lead Development Team discussions via telephone and email regarding assigned drug metabolism and pharmacokinetics efforts. • Analyze and interpret data for pharmacokinetics drug discovery, development, and translational projects.

Key facts

NIH application ID
11059582
Project number
75N95022P00346-P00004-0-2
Recipient
WHITE GLOBAL PHARMA CONSU
Principal Investigator
RONALD WHITE
Activity code
N02
Funding institute
NIH
Fiscal year
2024
Award amount
$10,800
Award type
Project period
2022-07-01 → 2025-06-30